Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Axe Finally Falls: Roche To Cut 4,800 Jobs
Pharmalot
Wednesday, November 17, 2010 - 11:45am
tags:
Roche, Genentech, layoffs
Drugmaker's Acquisitions to Weigh on Credit Ratings, Moody's Analysts Say
Bloomberg
Wednesday, November 17, 2010 - 11:44am
tags:
M&A, credit rating, Pfizer, King, Crucell, JNJ
Pfizer Unit Downplayed Prempro’s Risks, Lawyer Says
Bloomberg
Wednesday, November 17, 2010 - 11:42am
tags:
Pfizer, Prempro, Wyeth, lawsuits, HRT
FDA Panel Backs Human Genome's Lupus Drug
TheStreet.com
Wednesday, November 17, 2010 - 11:42am
tags:
FDA, advisory panels, lupus, Benlysta, Human Genome Sciences
Amarin: Pending Catalysts, Potential Breakthrough
Seeking Alpha
Tuesday, November 16, 2010 - 1:24pm
tags:
Amarin
Anthera Seeks to Tap Heart Attack Market by Blocking Inflammation
Motley Fool
Tuesday, November 16, 2010 - 1:22pm
tags:
Anthera, heart attacks
Cost-Cutting at Pfizer: Layoffs and Shared Hotel Rooms Up the Misery
BNET Pharma
Tuesday, November 16, 2010 - 12:40pm
tags:
layoffs, Pfizer
Dead in the Water? Glaxo’s Fish Oil Pill and A-Fib
Seeking Alpha
Tuesday, November 16, 2010 - 12:39pm
tags:
GSK, fish oil, atrial fibrillation, Lovaza
Are Shorts Watching This Number at Qiagen?
Motley Fool
Tuesday, November 16, 2010 - 12:05pm
tags:
Qiagen
Pharmacyclics: Showing Promise
Seeking Alpha
Tuesday, November 16, 2010 - 12:03pm
tags:
Pharmacyclics, Pfizer, Protalix BioTherapeutics, Sanofi, Genzyme
Endo Plans Debt After Most Sales in Six Weeks: New Issue Alert
Bloomberg
Tuesday, November 16, 2010 - 12:00pm
tags:
Endo
Doctors say blood-clot drug race too close to call
Reuters
Tuesday, November 16, 2010 - 11:59am
tags:
blood thinners, Pradaxa, Xarelto, Bayer, JNJ, Boehringer Ingelheim
Eisai Plans Sale of Cancer Medicine in the U.S. as Aricept Protection Ends
Bloomberg
Tuesday, November 16, 2010 - 11:57am
tags:
Eisai, Aricept, breast cancer, Eribulin
Human Genome: FDA Panel Live Blog
TheStreet.com
Tuesday, November 16, 2010 - 11:56am
tags:
Human Genome Sciences, FDA, advisory panels, Benlysta
Bristol-Myers Partner Otsuka Wins Abilify Ruling
Bloomberg
Tuesday, November 16, 2010 - 9:36am
tags:
Otsuka, Bristol-Myers Squibb, Abilify, patents, Teva Pharmaceuticals, Sun Pharma, Sandoz, Apotex
Johnson & Johnson Hid Antibiotic’s Risk, Lawyer Says
Bloomberg
Tuesday, November 16, 2010 - 9:33am
tags:
JNJ, antibiotics, Levaquin
Novartis closes in on growth formula
FT.com
Monday, November 15, 2010 - 8:51pm
tags:
Novartis, M&A, Alcon
Big Pharma’s Comeback?
Forbes
Monday, November 15, 2010 - 8:50pm
tags:
Big Pharma, JNJ, Xarelto, Bayer
Loss Widens at Isis Pharma
Yahoo/Zacks.com
Monday, November 15, 2010 - 8:48pm
tags:
earnings, Isis Pharmaceuticals
A Mega-Blockbuster Showdown
Motley Fool
Monday, November 15, 2010 - 6:28pm
tags:
Boehringer Ingelheim, Pradaxa, Bayer, Xarelto, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.